Oleic Acid

Oleic Acid

SCHEMBL873180

CCCCCCCC/C=C\CCCCCCCC(=O)[O-].CCCCCCCC/C=C\CCCCCCCC(=O)[O-].[Na+].[Na+]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Oleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 known ✓ P0DMS8 1/20 0.66
▸ PTGS1 known ✓ P23219 1/20 0.66
▸ PPARG known ✓ P37231 1/20 0.66
▸ FABP3 P05413 9/20 0.96
▸ TERT O14746 3/20 0.66
▸ MAPT P10636 2/20 0.66
▸ BLM P54132 2/20 0.66
▸ HSD17B10 Q99714 2/20 0.66
▸ FABP4 P15090 2/20 0.66
▸ GMNN O75496 1/20 0.66
▸ USP2 O75604 1/20 0.66
▸ LMNA P02545 1/20 0.66
▸ CYP1A2 P05177 1/20 0.66
▸ POLB P06746 1/20 0.66
▸ CYP2C9 P11712 1/20 0.66
▸ ALOX15 P16050 1/20 0.66
▸ APEX1 P27695 1/20 0.66
▸ CYP2C19 P33261 1/20 0.66
▸ RECQL P46063 1/20 0.66
▸ NPSR1 Q6W5P4 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9356018 1.00 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10
Oleic Acid SCHEMBL3803217 1.00 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10
Vaccenic Acid SCHEMBL9356059 1.00 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10
SCHEMBL25399853 1.00 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10
Vaccenic Acid SCHEMBL9359850 1.00 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10
SCHEMBL25400903 1.00 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10
Nervonic Acid SCHEMBL25231555 1.00 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10
Palmitoleic Acid SCHEMBL25179789 1.00 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10
Palmitoleic Acid SCHEMBL141872 1.00 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10
Palmitoleic Acid SCHEMBL141874 1.00 FABP3 (0.96) FABP3TERTMAPTBLMHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114191323-B Gemini glutamic acid amino acid surfactant composition, and preparation method and application thereof 岳阳科罗德联合化学工业有限公司 2024-03-26 — — CN claimed
CN-119968452-A Perfume mixture (VI) 西姆莱斯股份公司 2025-05-09 — — CN disclosed
CN-119790128-A Perfume mixture (III) 西姆莱斯股份公司 2025-04-08 — — CN disclosed
CN-119317696-A Perfume mixture (V) 西姆莱斯股份公司 2025-01-14 — — CN disclosed
CN-119317695-A Perfume mixture (V) 西姆莱斯股份公司 2025-01-14 — — CN disclosed
CN-119255980-A Perfume with cyclopropyl structure 西姆莱斯股份公司 2025-01-03 — — CN disclosed
WO-2024095947-A1 WATER-IN-OIL EMULSION COSMETIC COMPOSITION 株式会社マンダム 2024-05-10 — — WO disclosed
CN-114160313-B Lepidolite flotation collector and application thereof 中南大学 2023-01-24 — — CN disclosed
CN-114160313-A Lepidolite flotation collector and application thereof 中南大学 2022-03-11 — — CN disclosed
CN-214490766-U Cooling pond of liquid isolating agent is made to oleic acid sodium 威海市新兴化工科技有限公司 2021-10-26 — — CN disclosed
US-9708579-B2 Lactic acid bacteria fermented substance and fermented milk food product containing the same KABUSHIKI KAISHA YAKULT HONSHA (JP) 2017-07-18 — — US disclosed
CN-104291455-B A kind of composite multi-component mine dirt dispersion agent and application thereof XIAMEN ZIJIN MINING TECHNOLOGY CO., LTD. (CN) 2016-02-24 — — CN disclosed
CN-104471050-A Visually contrasting aesthetic particles having increased water solubility, particularly useful for combination with powdered or granular compositions AMCOL INTERNATIONAL CORP 2015-03-25 — — CN disclosed
CN-104291455-A Composite multi-element mine scale inhibition and dispersion agent and application thereof XIAMEN ZIJIN MINING & METALLURG TECHNOLOGY CO LTD 2015-01-21 — — CN disclosed
EP-2618815-A2 PHARMACEUTICAL COMPOSITIONS FOR CALANOLIDES, THEIR DERIVATIVES AND ANALOGUES, AND PROCESS FOR PRODUCING THE SAME Craun Research Sdn Bhd (MY) 2013-07-31 — — EP disclosed
WO-2012039596-A2 PHARMACEUTICAL COMPOSITIONS FOR CALANOLIDES, THEIR DERIVATIVES AND ANALOGUES, AND PROCESS FOR PRODUCING THE SAME CRAUN RESEARCH SDN BHD (MY) 2012-03-29 — — WO disclosed
EP-2361678-A1 CERAMIDE DISPERSION AND METHOD FOR PRODUCING SAME FUJIFILM Corporation (JP) 2011-08-31 — — EP disclosed
US-20080292751-A1 Lactic Acid Bacteria Fermented Substance and Fermented Milk Food Product Containing the Same KABUSHIKI KAISHA YAKULT HONSHA (JP) 2008-11-27 — — US disclosed
EP-1884566-A1 LACTIC ACID BACTERIA FERMENTED SUBSTANCE AND FERMENTED MILK FOOD PRODUCT CONTAINING THE SAME Kabushiki Kaisha Yakult Honsha (JP) 2008-02-06 — — EP disclosed
US-20060287206-A1 Detergent bar and process for manufacture CONOPCO, INC. D/B/A UNILEVER 2006-12-21 — — US disclosed
Send feedback